INVO Fertility, Inc.
$2.28
▼
-3.83%
2026-04-21 07:37:00
www.invobioscience.com
NCM: IVF
Explore INVO Fertility, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.39 M
Current Price
$2.28
52W High / Low
$384 / $1.92
Stock P/E
—
Book Value
$-22.34
Dividend Yield
—
ROCE
-26.69%
ROE
-133.37%
Face Value
—
EPS
$-1,474.4
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
33
Beta
—
Debt / Equity
72.39
Current Ratio
0.12
Quick Ratio
0.06
Forward P/E
-0.09
Price / Sales
2.01
Enterprise Value
$13.52 M
EV / EBITDA
-1.9
EV / Revenue
1.95
Rating
None
Target Price
$20
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 2. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 3. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 4. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
| 5. | AVITA Medical, Inc. | $5 | — | $157.45 M | — | 676.75% | 799.72% | $10.29 / $3.22 | $-0.55 |
| 6. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 7. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 1.76 M | 1.86 M | 1.64 M | 1.69 M | 1.43 M |
| Operating Profit | -1.64 M | -1.59 M | -2.46 M | -3.46 M | -1.3 M |
| Net Profit | -2.64 M | -5.28 M | -17.4 M | -3.62 M | -1.63 M |
| EPS in Rs | -0.38 | -0.76 | -2.5 | -0.52 | -0.23 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 6.53 M | 3.02 M | 0.82 M | 4.16 M |
| Operating Profit | -7.61 M | -6.77 M | -10.63 M | -5.22 M |
| Net Profit | -9.1 M | -8.03 M | -10.89 M | -6.65 M |
| EPS in Rs | -1.31 | -1.15 | -1.56 | -0.96 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 46.45 M | 18.51 M | 3.71 M | 10.47 M |
| Total Liabilities | 33.7 M | 17.61 M | 4.69 M | 3.16 M |
| Equity | 12.75 M | 0.89 M | -0.98 M | 7.31 M |
| Current Assets | 1.32 M | 1.26 M | 0.62 M | 6.31 M |
| Current Liabilities | 17.93 M | 8 M | 3.34 M | 1.25 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -2.97 M | -4.76 M | -6.6 M | -6.03 M |
| Investing CF | 0.36 M | -2.49 M | -0.08 M | -2.15 M |
| Financing CF | 3.12 M | 7.39 M | 1.09 M | 3.77 M |
| Free CF | -3.16 M | -5.2 M | -6.62 M | -6.48 M |
| Capex | -0.18 M | -0.44 M | -0.01 M | -0.45 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 116.25% | 267.38% | -80.24% | — |
| Earnings Growth % | -13.21% | 26.24% | -63.68% | — |
| Profit Margin % | -139.25% | -266% | -1324.81% | -159.97% |
| Operating Margin % | -116.56% | -224.04% | -1292.45% | -125.39% |
| Gross Margin % | 44% | 35.96% | -3.48% | 96.51% |
| EBITDA Margin % | -109.35% | -227.77% | -1307.83% | -125.45% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-27 | 1:0.2 |
| 2025-11-28 | 1:0.125 |
| 2025-07-21 | 1:0.333333 |
| 2025-03-18 | 1:0.0833333 |
| 2023-07-28 | 1:0.05 |